Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS

Journal of General Virology

Volumn 78, Issue 8, 1997, Pages 1913-1918

  Van Baalen, Carel A ^a   Pontesilli, Oscar ^b   Huisman, Robin C ^a   Geretti, Anna Maria ^a,d   Klein, Michèl R ^b   De Wolf, Frank ^b   Miedema, Frank ^b   Gruters, Rob A ^a,c   Osterhaus, Albert D M E ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITÉ DE LYON   (France)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

REV PROTEIN; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030863582     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-8-1913     Document Type: Article

References (34)

1. Bollinger, R. C., Egan, M. A., Chun, T., Mathieson, B. & Siliciano, R. F. (1996). Cellular immune responses to HIV-1 in progressive and non-progressive infections. AIDS 10, S85-S96.
2. Boom, R., Sol, C. J. A., Salimans, M. M. M., Jansen, C. L., Wertheim-van Dillen, P. M. E. & Van der Noordaa, J. (1991). A rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology 28, 495-503.
3. Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M. & Oldstone, M. B. (1994). Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viraemia in primary human immunodeficiency virus type 1 infection. Journal of Virology 68, 6103-6110.
4. Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A. & Shaw, G. M. (1997). Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Medicine 3, 205-211.
5. Carmichael, A., Jin, X., Sissons, P. & Borysiewicz, L. (1993). Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. Journal of Experimental Medicine 177, 249-256.
6. Connor, R. I. & Ho, D. D. (1994). Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. Journal of Virology 68, 4400-4408.
7. Couillin, I., Culmann-Penciolelli, B., Gomard, E., Choppin, J., Levy, J. P. & Saragosti, S. (1994). Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. Journal of Experimental Medicine 180, 1129-1134.
8. Embretson, J., Zupanic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K. & Haase, A. T. (1993). Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359-362.
9. Geretti, A. M., Dings, M. E. M., Van Els, C. A. C. M., Van Baalen, C. A., Wijnholds, F. J., Borleffs, J. C. C. & Osterhaus, A. D. M. E. (1996). Human immunodeficiency virus type 1 (HIV-1)- and Epstein-Barr virus-specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1-infected persons. Journal of Infectious Diseases 174, 34-45.
10. Goulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M., Giangrande, P., Luzzi, G., Morgan, B., Edwards, A., McMichael, A. J. & Rowland-Jones, S. (1997). Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Medicine 3, 212-217.
11. Harrer, T., Harrer, E., Kalams, S. A., Barbosa, P., Trocha, A., Johnson, R. P., Elbeik, T., Feinberg, M. B., Buchbinder, S. P. & Walker, B. D. (1996). Cytotoxic T lymphocytes in asymptomatic long-term non-progressing HIV-1 infection: breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. Journal of Immunology 156, 2616-2623.
12. Haynes, B. F., Pantaleo, G. & Fauci, A. S. (1996). Towards an understanding of the correlates of protective immunity to HIV infection. Science 271, 324-328.
13. Hulskotte, E. G., Geretti, A. M., Siebelink, K. H., Van Amerongen, G., Cranage, M. P., Rud, E. W., Norley, S. G., De Vries, P. & Osterhaus, A. D. (1995). Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5). Journal of Virology 69, 6289-6296.
14. Johnson, R. P. & Walker, B. D. (1994). Cytotoxic T lymphocytes in human immunodeficiency virus infection: responses to structural proteins. Current Topics in Microbiology and Immunology 189, 35-63.
15. Jurriaans, S., Van Gemen, B., Weverling, G. J., Van Strijp, D., Nara, P., Coutinho, R., Koot, M., Schuitemaker, H. & Goudsmit, J. (1994). The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology 204, 223-233.
16. Kalams, S. A., Johnson, R. P., Dynan, M. J., Hartman, K. E., Harrer, T., Harrer, E., Trocha, A., Blattner, W. A., Buchbinder, S. P. & Walker, B. D. (1996). T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed at a minor in vivo variant. Journal of Experimental Medicine 183, 1669-1679.
17. Kaslow, R. A., Carrington, M., Apple, R., Park, L., Munoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C., Detels, R., Blattner, W., Phair, J., Erlich, H. & Mann, D. L. (1996). Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Medicine 2, 405-411.
18. Klein, M. R. & Miedema, F. (1995). Long-term survivors of HIV-1 infection. Trends in Microbiology 3, 386-391.
19. Klein, M. R., Keet, I. P. M., D'Amaro, J., Bende, R. J., Hekman, A., Mesman, B., Koot, M., De Waal, L. P., Coutinho, R. A. & Miedema, F. (1994). Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam Cohort of homosexual men. Journal of Infectious Diseases 169, 1244-1249.
20. Klein, M. R., Van Baalen, C. A., Holwerda, A. M., Kerkhof Garde, S. R., Bende, R. J., Keet, I. P. M., Eeftinck-Schattenkerk, J. M., Osterhaus, A. D. M. E., Schuitemaker, H. & Miedema, F. (1995). Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: different for rapid progressors and long-term asymptomatics. Journal of Experimental Medicine 181, 1365-1372.
21. Koenig, S., Conley, A. J., Brewah, Y. A., Jones, G. M., Leath, S., Boots, L. J., Davey, V., Pantaleo, G., Demarest, J. F., Carter, C., Wannebo, C., Yannelli, J. R., Rosenberg, S. A. & Lane, H. C. (1995). Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nature Medicine 1, 330-336.
22. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. & Ho, D. D. (1994). Temporal association of cellular immune responses with the initial control of viraemia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 68, 4650-4655.
23. Lamhamedi-Cherradi, S., Culmann-Penciolelli, B., Guy, B., Ly, T. D., Goujard, C., Guillet, J. G. & Gomard, E. (1995). Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection. AIDS 9, 421-426.
24. Mellors, J. W., Rinaldo, C. R., Jr, Gupta, P., White, R. M., Todd, J. A. & Kingsley, L. A. (1996). Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167-1170.
25. Pantaleo, G., Demarest, J. F., Soudeyns, H., Graziosi, C., Denis, F., Adelsberger, J. W., Borrow, P., Saag, M. S., Shaw, G. M., Sekaly, R. P. and others (1994). Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370, 463-467.
26. Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R. M., Rizza, C. R. & McMichael, A. J. (1991). Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-459.
27. Rammensee, H. G., Friede, T. & Stevanoviic, S. (1995). MHC ligands and peptide motifs: first listing. Immunogenetics 41, 178-228.
28. Ranki, A., Lagerstedt, A., Ovod, V., Aavik, E. & Krohn, K. J. (1994). Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Archives of Virology 139, 365-378.
29. Rinaldo, C., Huang, X. L., Fan, Z. F., Ding, M., Beltz, L., Logar, A., Panicali, D., Mazzara, G., Liebmann, J., Cottrill, M. and others (1995). High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term non-progressors. Journal of Virology 69, 5838-5842.
30. Riviere, Y., Robertson, M. N. & Buseyne, F. (1994). Cytotoxic T lymphocytes in human immunodeficiency virus infection: regulator genes. Current Topics in Microbiology and Immunology 189, 65-74.
31. Riviere, Y., McChesney, M. B., Porrot, F., Tanneau-Salvadori, F., Sansonetti, P., Lopez, O., Pialoux, G., Feuillie, V., Mollereau, M., Chamaret, S. and others (1995). Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Research and Human Retroviruses 11, 903-907.
32. Seshamma, T., Bagasra, O., Trono, D., Baltimore, D. & Pomerantz, R. J. (1992). Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 89, 10663-10667.
33. Van Baalen, C. A., Klein, M. R., Geretti, A. M., Keet, I. P. M., Miedema, F., Van Els, C. A. C. M. & Osterhaus, A. D. M. E. (1993). Selective in vitro expansion of HLA class I-restricted HIV-1 gag specific CD8+ T cells from seropositive individuals: identification of CTL epitopes and precursor frequencies. AIDS 7, 781-786.
34. Van Baalen, C. A., Klein, M. R., Huisman, R. C., Dings, M. E. M., Kerkhof Garde, S. R., Geretti, A. M., Gruters, R., Van Els, C. A. C. M., Miedema, F. & Osterhaus, A. D. M. E. (1996). Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1. Journal of General Virology 77, 1659-1665.